Filing Details

Accession Number:
0001104659-24-003435
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-11 20:00:28
Reporting Period:
2024-01-09
Accepted Time:
2024-01-11 20:00:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1377121 Protagonist Therapeutics Inc PTGX Pharmaceutical Preparations (2834) 980505495
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1763923 Suneel Gupta C/O Protagonist Therapeutics, Inc.
7707 Gateway Blvd., Suite 140
Newark CA 94560-1160
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-09 5,000 $7.38 192,567 No 4 M Direct
Common Stock Disposition 2024-01-09 5,000 $25.00 187,567 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-01-09 5,000 $0.00 5,000 $7.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,000 2029-01-14 No 4 M Direct
Footnotes
  1. Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 25, 2023.
  2. These stock options are fully vested.